Period of time： 2014年1期
Publisher： Informa Healthcare
Founded in： 1996
Total resources： 42
ISSN： 1472-8214
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 3,issue 1
Menu
Opportunities in pain therapy:beyond the opioids and NSAIDs
By Kowaluk E.A.,Arneric S.P.,Williams M. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.
Access to resources
Recommend
The therapeutic applications of cannabinoid agonists and antagonists
By Petitet F.,Imperato A. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.Vascular and non-vascular approaches to the treatment of stroke
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.Selective modulation of muscarinic receptor subtypes: therapeutic potential
By Eglen R.M.,Hegde S.S. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.By Smith R.,Cunningham G.,Kivlighn S. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.The endothelin system:a novel therapeutic target in cardiovascular disease
By Strachan F.E.,Webb D.J. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.Imidazoline receptor ligands:cardiovascular applications
By Bousquet P.,Feldman J.,Monassier L. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.The vulnerable atherosclerotic plaque
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.Calcium antagonists as anti-atherosclerotic agents
By Gaviraghi G.,Trist D. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.By Harwood Jr H.J.,Hamanaka E.S. in (1998)
Expert Opinion on Emerging Drugs,volume 3,issue 1 , Vol. 3, Iss. 1, 1998-06 , pp.
Previous
Next